findmyKOL
Clinical trialNCT00003611CompletedInterventional

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

SponsorAlliance for Clinical Trials in OncologyEnrollment129Non-melanomatous Skin Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of acitretin may be an effective way to prevent the recurrence or further development of skin cancer. PURPOSE: Randomized clinical trial to study the effectiveness of acitretin in preventing skin cancers in patients with at least two previously treated skin cancers who have undergone organ transplantation.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Scottsdale Oncology Program

    Scottsdale, Arizona, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Ccop - Illinois Oncology Research Association

    Peoria, Illinois, United States

  • Ccop - Carle Cancer Center

    Urbana, Illinois, United States

  • Ccop - Iowa Oncology Research Association

    Des Moines, Iowa, United States

  • Ccop - Wichita

    Wichita, Kansas, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Centracare Health Plaza

    Saint Cloud, Minnesota, United States

  • Medcenter One Health System

    Bismarck, North Dakota, United States

  • Rapid City Regional Hospital

    Rapid City, South Dakota, United States

  • Ccop - Sioux Community Cancer Consortium

    Sioux Falls, South Dakota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Acitretin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2000
Primary completion
28 Feb 2003
Completion
30 Jun 2003
Last update posted
13 Jul 2016
Registered enrollment
129
Registry id
NCT00003611
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.